Mark Rothera
Overview
Mark Rothera received an average of $4M in total compensation, including $343K in salary, at Orchard Therapeutics plc between 2019 and 2020. Mark Rothera also received an average of $2M at PTC Therapeutics from 2013 to 2017.
- 2020
- 2019
- 2017
- 2016
- 2015
- 2014
- 2013
Orchard Therapeutics plcFormer CEO
Orchard Therapeutics plcFormer CEO
PTC TherapeuticsFormer Chief Commercial Officer
PTC TherapeuticsChief Commercial Officer
PTC TherapeuticsChief Commercial Officer
PTC TherapeuticsChief Commercial Officer
PTC TherapeuticsChief Commercial Officer
Source: SEC filings on April 28, 2021, April 30, 2018, April 27, 2017, and April 28, 2016.
Related executives
We found 13 more executives who work or worked at Orchard Therapeutics plc and PTC Therapeutics.
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
Emily Hill
PTC Therapeutics
Chief Financial Officer
Bobby Gaspar
Orchard Therapeutics plc
Chief Executive Officer
Mark Boulding
PTC Therapeutics
Chief Legal Officer
Neil Almstead
PTC Therapeutics
Chief Technical Operations Officer
Eric Pauwels
PTC Therapeutics
Chief Business Officer
Frank Thomas
Orchard Therapeutics plc
Chief Operating Officer
Marcio Souza
PTC Therapeutics